PHARMA

Quarterly rpt on consolidated results for the financial period ended 31 Dec 2015

PHARMANIAGA BERHAD

Financial Year End 31 Dec 2015
Quarter 4 Qtr
Quarterly report for the financial period ended 31 Dec 2015
The figures have not been audited

Attachments

Pharma Q4 2016 Fin Result.pdf
298.8 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
31 Dec 2015

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31 Dec 2015
31 Dec 2014
31 Dec 2015
31 Dec 2014
$$'000
$$'000
$$'000
$$'000
1 Revenue
680,150
627,103
2,189,312
2,122,933
2 Profit/(loss) before tax
23,717
37,854
112,722
125,580
3 Profit/(loss) for the period
16,041
36,621
84,584
94,225
4 Profit/(loss) attributable to ordinary equity holders of the parent
16,062
36,697
84,044
93,844
5 Basic earnings/(loss) per share (Subunit)
6.20
14.18
32.46
36.25
6 Proposed/Declared dividend per share (Subunit)
7.00
12.00
30.00
28.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
2.0450
2.0340

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 15 Feb 2016
Category Financial Results
Reference Number FRA-15022016-00001